US
U.S. Stem Cell, Inc.
USRM · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $64.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.78x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 70.11%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 3,483.21%
Op. margin 2,096.90%
FCF margin 371.55%
Quality
79 /100
Excellent ROA 4,200.45%
Asset turnover 1.21x
ROIC 29.95%
Debt
50 /100
Moderate Int. coverage -3.14x
Net debt/EBITDA -4.12x
Current ratio 0.00x
Stability
46 /100
Moderate Rev. volatility 31.72%
EPS volatility 22.33%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about USRM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Tomas
Employees
11
Headquarters
Sunrise